14158 Results (Page 435 of 567)
All Market Research Reports
US eHealth Market Analysis
The US eHealth market is projected to grow from $70 Bn in 2022 to $223 Bn by 2030, registering a CAGR of 15.6% during the forecast period of 2022-30. The US eHealth market is driven by factors such as increasing healthcare costs, an aging population, the prevalence of chronic diseases, and the need to improve healthcare outcomes. Digital technologies and services are seen as a way to address these challenges by improving patient engagement, increasing access to care, and reducing healthcare costs. Amazon Pharmacy is a recent entrant to the e-pharmacy market, offering prescription medications and other healthcare products through its online marketplace.
Vietnam Diabetes Devices Market Analysis
The Vietnam Diabetes Devices Market is expected to grow from $114 Mn in 2022 to $202 Mn in 2030 with a CAGR of 7.43% for the forecasted year 2022-2030. Diabetes has been identified in over 5.2 million people in Vietnam, making it one of the most widespread diseases worldwide. As diabetes prevalence increases in Vietnam, there is a growing need for diabetes devices to control the condition. The market is segmented by type and by the end user. Some key players in this market include USM Healthcare, Vinamed, CPT Sutures, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
US Depression Therapeutics Market Analysis
The US depression therapeutics market is projected to grow from $4.2 Bn in 2022 to $5.5 Bn by 2030, registering a CAGR of 3.2% during the forecast period of 2022-30. The key players in the market include major pharmaceutical companies such as Pfizer, Inc., Eli Lilly and Company, and Johnson & Johnson, as well as smaller companies, focused on developing innovative new treatments and therapies for depression. Factors driving the growth of the US Depression Therapeutics Market include the increasing prevalence of depression, the growing acceptance of mental health issues, and the development of new and innovative treatments and therapies.
Mexico Diabetes Devices Market Analysis
The Mexico Diabetes Devices Market is expected to witness growth from $341 Mn in 2022 to $606 Mn in 2030 with a CAGR of 7.45% for the forecasted year 2022-2030. The demand for diabetes devices is rising as the Mexican population's discretionary income rises. As the economy improves and the middle class grows, this tendency is anticipated to persist. The market is segmented by type and by the end user. Some key players in this market include Famous Tijuana, Medstent, Medyssey, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
US Cardiovascular Diseases Therapeutics Market Analysis
The US Cardiovascular Disease (CVD) therapeutics market is projected to grow from $68.3 Bn in 2022 to $102.6 Bn by 2030, registering a CAGR of 5.22% during the forecast period of 2022-30. CVD is the leading cause of death in the US and affects a significant portion of the population. This high prevalence of CVD creates a large market for CVD treatments and drives demand for new and innovative therapies. Some of the key players in the US CVD therapeutics market include Pfizer, Novartis, Merck & Co., Sanofi, Bristol-Myers Squibb, and Amgen.
US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
The US ADHD (Attention Deficit Hyperactivity Disorder) therapeutic market is projected to grow from $12.4 Bn in 2022 to $19.1 Bn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. ADHD is one of the most common neurodevelopmental disorders in children, with an estimated prevalence of 6-9% in the US. The rising prevalence of ADHD is driving the demand for effective treatments and contributing to the growth of the market. Some key players in the US ADHD therapeutic market include Shire (now part of Takeda Pharmaceutical Company), Pfizer Inc., Novartis International AG, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline plc.
Turkey Diabetes Devices Market Analysis
The Turkey Diabetes Devices Market is expected to witness growth from $182 Mn in 2022 to $329 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-2030. Affordable healthcare options, reasonably lax regulatory requirements, and cost-effective labour are a few of the factors driving diabetic device manufacturers to grow their businesses in Turkey. The market is segmented by type and by the end user. Some key players in this market include Megasan Medikal, Kare Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Tanzania Diabetes Devices Market Analysis
The Tanzania Diabetes Devices Market is expected to witness growth from $9 Mn in 2022 to $17 Mn in 2030 with a CAGR of 8.10 % for the forecasted year 2022-2030. Tanzania's healthcare infrastructure has recently undergone improvements, including the development of medical facilities and the accessibility of qualified medical professionals. This improves diabetes patients’ access to diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Spain Diabetes Devices Market Analysis
The Spain Diabetes Devices Market is expected to witness growth from $439 Mn in 2022 to $710 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In Spain, diabetes instances have been steadily increasing in recent years. This tendency, which is anticipated to continue, will lead to an increase in the market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Medlumics, Ekuore, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Poland Diabetes Devices Market Analysis
The Poland Diabetes Devices Market is expected to witness growth from $132 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.65% for the forecasted year 2022-2030. Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market is segmented by type and by the end user. Some key players in this market include Skamex, SORIMEX, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Netherlands Diabetes Devices Market Analysis
The Netherlands Diabetes Devices Market is expected to witness growth from $59 Mn in 2022 to $107 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-2030. There has been a consistent rise in the number of diabetes diagnoses in the Netherlands. Manufacturers of diabetes devices now have a great chance to meet the rising demand for diabetes management solutions. The market is segmented by type and by the end user. Some key players in this market include Hy2Care B.V, InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V, Roche and Dexcom.
Italy Diabetes Devices Market Analysis
The Italy Diabetes Devices Market is expected to witness growth from $546 Mn in 2022 to $916 Mn in 2030 with a CAGR of 6.70% for the forecasted year 2022-2030. In Italy, the number of cases of diabetes has been gradually rising in recent years. The market for diabetes devices and associated goods will increase as a result of this trend. The market is segmented by type and by the end user. Some key players in this market include Ormesa S.R.L, Angelantoni Life Science, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
US Coronary Stents Market Analysis
The US coronary stents market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. The US coronary stents market is driven by several factors, including the high prevalence of coronary artery disease (CAD) in the US, advances in stent technology, and increasing demand for minimally invasive procedures. The market is highly competitive, with several major players such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic dominating the market. These companies invest heavily in research and development to develop innovative stent technologies that provide better outcomes for patients.
US Biomaterials in Healthcare Market Analysis
The US biomaterials in the healthcare market are projected to grow from $65.6 Bn in 2022 to $153.4 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-30. Chronic diseases such as cardiovascular disease, cancer, and diabetes are on the rise in the US. The market is highly competitive, with several key players, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. These companies invest heavily in research and development to develop new biomaterials and improve the performance of existing ones.
Germany Diabetes Devices Market Analysis
The Germany Diabetes Devices Market is expected to witness growth from $832 Mn in 2022 to $1267 Mn in 2030 with a CAGR of 5.40% for the forecasted year 2022-2030. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. The market is segmented by type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
France Diabetes Devices Market Analysis
The France Diabetes Devices Market is expected to witness growth from $625 Mn in 2022 to $1011 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In France, insulin pumps have become increasingly popular due to their ability to improve glycemic control and enhance the quality of life for diabetes patients in France. Manufacturers that offer insulin pumps with advanced features and better usability are likely to see growth in the market. The market is segmented by type and by the end user. Some key players in this market include Nanosonics France, SAMMEX Medical, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
China Diabetes Devices Market Analysis
The China Diabetes Devices Market is expected to grow from $1.82 Bn in 2022 to $3.56 Bn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. Diabetes is a common condition in China, where the demand for diabetes-related products and devices is rising. The prevalence of diabetes is anticipated to increase as the population ages and urbanizes, providing significant opportunities for diabetes device manufacturers. The market is segmented by type and by the end user. Some key players in this market include Lepu Medical Technology, MicroPort, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
US Cardiac Monitoring Devices Market Analysis
The US cardiac monitoring device market is projected to grow from $12.1 Bn in 2022 to $15 Bn by 2030, registering a CAGR of 2.7% during the forecast period of 2022-30. The US cardiac monitoring device market is expected to continue growing as the demand for accurate and reliable Cardiac Monitoring devices increases. Medtronic is a leading medical device company that offers a range of cardiac monitoring devices, including implantable cardiac monitors, pacemakers, and defibrillators.
US ENT Devices Market Analysis
The US ENT devices market is projected to grow from $9.7 Bn in 2022 to $13.1 Bn by 2030, registering a CAGR of 3.75% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. According to the National Institute on Deafness and Other Communication Disorders, approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the market include Cochlear Limited, William Demant Holding A/S, Medtronic plc, Stryker Corporation, and Olympus Corporation.
US Liver Diseases Therapeutics Market Analysis
The US liver disease therapeutics market is projected to grow from $9.7 Bn in 2022 to $13 Bn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. Liver diseases such as hepatitis, liver cancer, and NAFLD are becoming increasingly prevalent in the US population, driving demand for effective treatments. Some of the key players operating in the US liver disease therapeutics market include Gilead Sciences, Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb, and Novartis AG. These companies are investing heavily in research and development to develop new and innovative treatments for liver disease and are expected to continue to drive the growth of the market in the coming years.
US Liver Cancer Therapeutics Market Analysis
The US liver cancer therapeutics market is projected to grow from $1.2 Bn in 2022 to $3.9 Bn by 2030, registering a CAGR of 15.6% during the forecast period of 2022-30. The market for liver cancer therapeutics in the US is driven by factors such as the increasing prevalence of liver cancer, the growing demand for effective treatment options, and advancements in technology and drug development. In addition, the increasing use of combination therapies, the development of targeted therapies, and the focus on personalized medicine are also contributing to the growth of this market. The major players operating in the US liver cancer therapeutics market include pharmaceutical companies such as Bristol-Myers Squibb, Bayer Healthcare, Pfizer Inc., Eisai Co., Ltd., and F. Hoffmann-La Roche AG.
US Infectious Disease Therapeutics Market Analysis
The US infectious disease therapeutics market is projected to grow from $50.3 Bn in 2022 to $60.6 Bn by 2030, registering a CAGR of 2.35% during the forecast period of 2022-30. Antibiotics are one of the most commonly prescribed classes of drugs for infectious diseases, but the rise of antibiotic-resistant bacteria has led to the development of new antibiotics and alternative therapies, such as antivirals and antifungals. Gilead Sciences is a biopharmaceutical company that develops and markets therapeutics for infectious diseases, including HIV/AIDS, hepatitis B and C, and influenza.
US Healthcare Claims Management Market Analysis
The US healthcare claims management market is projected to grow from $11 Bn in 2022 to $53 Bn by 2030, registering a CAGR of 21.4% during the forecast period of 2022-30. Healthcare organizations are increasingly focused on improving patient outcomes and delivering high-quality care. This includes ensuring that claims are processed accurately and quickly so that patients can receive the care they need in a timely manner. There are several key players in the market, including Cerner Corporation, Allscripts Healthcare Solutions, Inc., and McKesson Corporation. These companies offer a range of solutions, including software and services, to help healthcare providers manage their claims and billing processes efficiently.
US Connected Healthcare Market Analysis
The US connected healthcare market is projected to grow from $28 Bn in 2022 to $182 Bn by 2030, registering a CAGR of 26.4% during the forecast period of 2022-30. The US Connected Healthcare market is highly competitive, with a wide range of companies offering products and services in this space. Major players include Apple, Google, Philips, and Samsung, as well as numerous startups and smaller companies. The widespread use of smartphones, tablets, and other mobile devices has led to the growth of mHealth technologies such as mobile health apps, wearables, and telehealth services, which enable patients to receive healthcare services remotely.
UAE Cardiac Surgery Instruments Market Analysis
The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
